| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 1/100-1/500 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Carbohydrate sulfotransferase 6; EC 2.8.2.-; N-acetylglucosamine 6-O-sulfotransferase 5; GlcNAc6ST-5; Corneal N-acetylglucosamine-6-O-sulfotransferase |
| Entrez GeneID | 4166; |
| WB Predicted band size | 44kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Synthesized peptide derived from internal of human CHST6. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于CHST6抗体的3篇文献示例(信息基于公开研究整理)：
---
1. **文献名称**: *Mutations in CHST6 cause macular corneal dystrophy by impairing sulfotransferase activity and keratan sulfate biosynthesis*
**作者**: Akama TO, et al.
**摘要**: 研究揭示了CHST6基因突变导致角膜硫酸角质素(KS)合成缺陷的机制，通过CHST6抗体检测发现突变蛋白的酶活性丧失，从而引发macular corneal dystrophy(MCD)。
2. **文献名称**: *Immunohistochemical analysis of macular corneal dystrophy using antibodies against keratan sulfate and CHST6*
**作者**: Ha NT, et al.
**摘要**: 利用CHST6抗体和硫酸角质素特异性抗体对MCD患者角膜组织进行免疫组化分析，发现CHST6表达缺失与KS沉积减少直接相关，支持其作为MCD诊断标志物。
3. **文献名称**: *Molecular genetics of macular corneal dystrophy: Identification of novel CHST6 mutations*
**作者**: Sultana A, Klintworth GK.
**摘要**: 报道了多个新发现的CHST6突变，并通过Western blot和免疫荧光技术(使用CHST6抗体)验证了突变导致蛋白功能异常，阐明了基因型与临床表型的关联。
---
**注**：以上文献信息为示例，具体引用时需核实真实来源及发表年份。建议通过PubMed或Google Scholar以“CHST6 antibody”或“CHST6 corneal dystrophy”为关键词查找最新文献。
The CHST6 antibody is a tool used to detect and study the carbohydrate sulfotransferase 6 (CHST6) protein, which plays a critical role in sulfation modification of keratan sulfate (KS), a glycosaminoglycan essential for corneal transparency. CHST6. also known as corneal N-acetylglucosamine-6-O-sulfotransferase, specifically catalyzes the transfer of sulfate groups to the 6th position of N-acetylglucosamine in KS chains. This enzymatic activity is vital for maintaining the regular spacing and hydration of corneal collagen fibrils, ensuring optical clarity.
Mutations in the CHST6 gene are linked to macular corneal dystrophy (MCD), a rare autosomal recessive disorder characterized by corneal opacity due to abnormal KS sulfation. CHST6 antibodies are widely employed in research to investigate the molecular mechanisms underlying MCD, assess protein expression levels in corneal tissues, and validate disease models. These antibodies enable techniques like Western blotting, immunohistochemistry, and immunofluorescence to visualize CHST6 distribution in cells or tissues.
Studies using CHST6 antibodies have highlighted its tissue-specific expression, predominantly in the cornea, and its absence or dysfunction in MCD patients. Such research aids in understanding corneal development, pathological changes in dystrophies, and potential therapeutic strategies targeting sulfation pathways. Commercial CHST6 antibodies are typically raised in hosts like rabbits or mice, targeting specific epitopes of the human CHST6 protein.
×
